In the current environment I think BOT management are being very smart. Anything on the forefront to new bacterial or viral killing technology is going to skyrocket over the next couple of years. It has now been embedded into the public’s psyche.
we are first by a long way at the moment, from a superbug gram positive killing perspective.
Ann: Antimicrobial Platform Update and Launch of BTX 1801 Study, page-57
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.015(5.17%) |
Mkt cap ! $433.1M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $1.164M | 4.100M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 534239 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 77302 | 2 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
-0.015 ( 2.61 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 29.0¢ | 27.5¢ | 2348390 | ||
| Last updated 15.59pm 28/05/2024 ? | |||||
| BOT (ASX) Chart |